1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow MK-1484: new trials by email Literature Review of MK-1484 trials Research Report on MK-1484
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001) MK-1484, Pembrolizumab - Advanced or Metastatic Solid Tumors | Phase 1 | Terminated | Merck Sharp & Dohme LLC | 30 | 2022-06-16 | 2026-10-21 |
Parkinson Disease 4, Autosomal Dominant Lewy Body (1)
Canada (1) · Israel (1) · Netherlands (1) · United States (1)
2023 (1)